Nephrogenex, Inc.
Records under this name other than patents Nephrogenex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Nephrogenex, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,428,533 | Inhibitors of Advanced Glycation End Products Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,214,799 | Methods for the Synthesis of Pyridoxamine Formerly held Term ended Term ended Feb 9, 2025 · High confidence | Term ended | Term ended Feb 9, 2025 | High confidence |
| US 8,431,712 | Methods for the Synthesis of Pyridoxamine Lapsed on the fee record Ended Apr 30, 2021 · Medium confidence | Lapsed on the fee record | Ended Apr 30, 2021 | Medium confidence |
| US 8,067,444 | Pyridoxamine for the Treatment of Diabetic Intermediaries and Post-Amadori Inhibition Lapsed on the fee record Ended Nov 29, 2019 · Medium confidence | Lapsed on the fee record | Ended Nov 29, 2019 | Medium confidence |